Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04648904 · ClinicalTrials.gov registry record · Early Phase 1
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
A Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT04648904 is a Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 71 participants, below the 129-participant average among 19 other Invasive Breast Cancer trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04648904, a Early Phase 1 study of Invasive Breast Cancer and Post-mastectomy, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see whether providing radiation on a shortened (compressed) schedule of 5 days in a row is a safe and effective approach to prevent cancer from coming back in people who have had a mastectomy.
Conditions Studied
Interventions
- RADIATION Radiotherapy
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2026-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04648904
The ClinicalTrials.gov registry entry for NCT04648904 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 19 other Invasive Breast Cancer trials with a reported enrollment target (45% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Invasive Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiotherapy is the first listed.
NCT04648904 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04648904 about?
NCT04648904 is a clinical study titled "Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer". The purpose of this study is to see whether providing radiation on a shortened (compressed) schedule of 5 days in a row is a safe and effective approach to prevent cancer from coming back in people who have had a mastectomy.
What is the current status of trial NCT04648904?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 71 participants. The study started on 2020-11-24. Estimated completion is 2026-11.
What conditions does trial NCT04648904 study?
This clinical trial studies the following conditions: Invasive Breast Cancer, Post-mastectomy.
What interventions are being tested in trial NCT04648904?
The interventions under investigation include: Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT04648904?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04648904 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Invasive Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
TRUDI: TDXD+Durva in HER2+/Low IBC
RECRUITING · Phase 2
-
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
RECRUITING · Phase 1
-
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
RECRUITING · Phase 2
-
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.